Obstetrics/Gynecology · Honolulu, HI
NPI
1790848638
Since 2006
Specialty
Obstetrics/Gynecology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1329 Lusitana St Ste B2
Honolulu, HI, 96813
Phone (808) 599-4200
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
1,229 services
Medicare patients, 2024
293
Average age 75
Drug cost, 2024
$537K
749 prescriptions
Company payments, 2025
$638
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harry N Yoshino I was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 154 times for 154 patients. In total Harry N Yoshino I billed 1,229 services in 18 codes, and Medicare paid $48K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 154 | 154 | $39.47 | $6,078 |
| 99213 Office E&M - Established | Office | 144 | 137 | $53.10 | $7,647 |
| 99212 Office E&M - Established | Office | 130 | 96 | $33.67 | $4,378 |
| 96372 Injection Administration | Office | 125 | 62 | $9.94 | $1,243 |
| 99214 Office E&M - Established | Office | 102 | 102 | $103.78 | $11K |
| 77080 Standard X-ray | Office | 57 | 57 | $42.21 | $2,406 |
| 99204 Office E&M - New | Office | 11 | 11 | $94.18 | $1,036 |
By year: 2022 $43K for 1,743 services; 2023 $29K for 760 services; 2024 $48K for 1,229 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 146 | 146 | $4.21 | $615 |
Medicare prescription drug claims, 2024
In 2024, the drug Harry N Yoshino I prescribed most often to Medicare patients was Raloxifene Hcl, with 193 prescriptions and refills. In total Harry N Yoshino I wrote 749 Medicare prescriptions that cost $537K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Raloxifene Hcl Generic | 193 | 578 | 62 | $28K |
| Prolia Denosumab | 190 | 1,137 | 109 | $328K |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 68 | 73 | 55 | $1,186 |
| Estradiol Generic | 56 | 294 | 36 | $1,720 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 41 | 47 | Under 11 | $116K |
| Myrbetriq Mirabegron | 24 | 72 | 13 | $31K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 18 | 20 | 16 | $229 |
| Premarin Estrogens, Conjugated | 14 | 41 | Under 11 | $7,474 |
| Hydrocortisone Generic | 12 | 12 | Under 11 | $184 |
| Valacyclovir Valacyclovir Hcl | 11 | 15 | Under 11 | $396 |
Brand drugs: 295 claims; generic drugs: 454 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harry N Yoshino I $638 ($638 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amgen Inc. with $368.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.